Company intelligence / Profile preview

Golden Meditech Javadi Precision Medicine Limited

Calabasas, California, United States

Ownership: Private
Development stage: Other

Overview

Operates a day clinic in the US providing personalized precision oncology treatments combining chemotherapy, immunotherapy, targeted therapy, and biological therapies based on next-generation sequencing for cancer patients, particularly those failed on standard treatments.

Therapeutic areas: Oncology
Modalities: ChemotherapyImmunotherapyTargeted therapyBiological therapies
Industry: Non-Academic Healthcare

Partnerships

Golden Meditech Holdings Limited (40% joint venture)Dr. Nader JavadiHope Health CenterUniversity of Texas at MD Anderson Cancer CenterLeading genetic labs in the USAI technology firms in healthcare

Beyond the preview

Go deeper on Golden Meditech Javadi Precision Medicine Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golden Meditech Javadi Precision Medicine Limited.

Explore the full profile